page_banner

Products

Tetraethyl ranelate CAS: 58194-26-6

Short Description:

Catalog Number: XD93862
Cas: 58194-26-6
Molecular Formula: C20H26N2O8S
Molecular Weight: 454.49
Availability: In Stock 
Price:  
Prepack:  
Bulk Pack: Request Quote

 


Product Detail

Product Tags

Catalog Number XD93862
Product Name Tetraethyl ranelate
CAS 58194-26-6
Molecular Formula C20H26N2O8S
Molecular Weight 454.49
Storage Details Ambient

 

Product Specification

Appearance White powder
Assay 99% min

 

Tetraethyl ranelate, also known as strontium ranelate, is a chemical compound that has been primarily used as a medication for the treatment of osteoporosis. Its molecular formula is C12H20O8S2Sr and it consists of two organic ranelic acid molecules bound to one strontium ion.The primary use of tetraethyl ranelate is to increase bone formation and decrease bone resorption, making it effective in the treatment and prevention of osteoporosis. Osteoporosis is a condition characterized by low bone density and increased risk of fractures. Tetraethyl ranelate works by stimulating the activity of osteoblasts, the cells responsible for building new bone, while inhibiting the activity of osteoclasts, the cells responsible for breaking down bone.Clinical trials have shown that tetraethyl ranelate can significantly reduce the risk of vertebral and non-vertebral fractures in patients with osteoporosis. It has also been found to improve bone mineral density, leading to stronger and healthier bones. These effects make tetraethyl ranelate a beneficial treatment option for individuals at risk of fractures due to osteoporosis.In addition to its effects on bone health, tetraethyl ranelate has shown potential in other areas of medicine. Some studies have suggested that it may have anti-inflammatory and antioxidant properties, which could make it useful in the treatment of other inflammatory conditions. It has also been investigated for potential use in treating cartilage degeneration and joint diseases.It is worth noting that the use of tetraethyl ranelate has been associated with certain side effects. These include increased risk of cardiovascular events, such as myocardial infarction and stroke, as well as rare cases of severe skin reactions. Due to these safety concerns, the use of tetraethyl ranelate has been restricted or discontinued in some countries. As with any medication, it is important to weigh the potential benefits against the risks and consult with a healthcare professional before starting treatment.In conclusion, tetraethyl ranelate is a medication primarily used for the treatment of osteoporosis. It works by increasing bone formation and decreasing bone resorption, leading to stronger bones and reduced risk of fractures. While its use has been associated with certain side effects, it has shown benefits in clinical trials and remains an option for individuals with osteoporosis, under appropriate medical supervision.


  • Previous:
  • Next:

  • Close

    Tetraethyl ranelate CAS: 58194-26-6